메뉴 건너뛰기




Volumn 10, Issue 4, 2015, Pages

Month 2 culture status and treatment duration as predictors of recurrence in pulmonary tuberculosis: Model validation and update

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAPENTINE; TUBERCULOSTATIC AGENT; QUINOLONE DERIVATIVE;

EID: 84928779344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125403     Document Type: Article
Times cited : (43)

References (19)
  • 1
    • 84894198937 scopus 로고    scopus 로고
    • WHO, Geneva. WHO/HTM/TB/2014.08. Available at
    • World Health Organization (2014) Global tuberculosis report 2014. WHO, Geneva. WHO/HTM/TB/2014.08. Available at http://www.who.int/tb/publications/global-report/en/.
    • (2014) Global Tuberculosis Report 2014
  • 2
    • 0027446941 scopus 로고
    • Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months
    • letter PMID: 8466107
    • Mitchison DA (1993) Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months [letter]. Am Rev Respir Dis 147: 1062-1063. PMID: 8466107
    • (1993) Am Rev Respir Dis , vol.147 , pp. 1062-1063
    • Mitchison, D.A.1
  • 3
    • 74549209135 scopus 로고    scopus 로고
    • Biomarkers for tuberculosis disease activity, cure, and relapse
    • PMID: 20113972
    • Wallis RS, Wang C, Doherty TM, Onyebujoh P, Vahedi M, Laang H et al. (2010) Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 10: 68-69. doi: 10.1016/S1473-3099(10)70003-7 PMID: 20113972
    • (2010) Lancet Infect Dis , vol.10 , pp. 68-69
    • Wallis, R.S.1    Wang, C.2    Doherty, T.M.3    Onyebujoh, P.4    Vahedi, M.5    Laang, H.6
  • 4
    • 84877309715 scopus 로고    scopus 로고
    • An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse
    • PMID: 23667677
    • Phillips PP, Fielding K, Nunn AJ (2013) An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse. PLoS One 8: e63840. doi: 10.1371/journal.pone.0063840 PMID: 23667677
    • (2013) PLoS One , vol.8 , pp. e63840
    • Phillips, P.P.1    Fielding, K.2    Nunn, A.J.3
  • 5
    • 84881114100 scopus 로고    scopus 로고
    • Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model
    • PMID: 23940699
    • Wallis RS, Wang C, Meyer D, Thomas N (2013) Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model. PLoS ONE 8: e71116. doi: 10.1371/journal.pone.0071116 PMID: 23940699
    • (2013) PLoS ONE , vol.8 , pp. e71116
    • Wallis, R.S.1    Wang, C.2    Meyer, D.3    Thomas, N.4
  • 6
    • 84908126151 scopus 로고    scopus 로고
    • Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
    • PMID: 25196020
    • Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR et al. (2014) Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis. N Engl J Med 371: 1577-1587. doi: 10.1056/NEJMoa1407426 PMID: 25196020
    • (2014) N Engl J Med , vol.371 , pp. 1577-1587
    • Gillespie, S.H.1    Crook, A.M.2    McHugh, T.D.3    Mendel, C.M.4    Meredith, S.K.5    Murray, S.R.6
  • 7
    • 84908147456 scopus 로고    scopus 로고
    • A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
    • PMID: 25337748
    • Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T et al. (2014) A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis. N Engl J Med 371: 1588-1598. doi: 10.1056/NEJMoa1315817 PMID: 25337748
    • (2014) N Engl J Med , vol.371 , pp. 1588-1598
    • Merle, C.S.1    Fielding, K.2    Sow, O.B.3    Gninafon, M.4    Lo, M.B.5    Mthiyane, T.6
  • 9
    • 69949099207 scopus 로고    scopus 로고
    • Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion
    • PMID: 19542476
    • Johnson JL, Hadad DJ, Dietze R, Noia Maciel EL, Sewali B, Gitta P et al. (2009) Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med 180: 558-563. doi: 10.1164/rccm.200904-0536OC PMID: 19542476
    • (2009) Am J Respir Crit Care Med , vol.180 , pp. 558-563
    • Johnson, J.L.1    Hadad, D.J.2    Dietze, R.3    Noia Maciel, E.L.4    Sewali, B.5    Gitta, P.6
  • 12
    • 76149124232 scopus 로고    scopus 로고
    • Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis
    • PMID: 20003697
    • Wang JY, Wang JT, Tsai TH, Hsu CL, Yu CJ, Hsueh PR et al. (2010) Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis. Int J Tuberc Lung Dis 14: 65-71. PMID: 20003697
    • (2010) Int J Tuberc Lung Dis , vol.14 , pp. 65-71
    • Wang, J.Y.1    Wang, J.T.2    Tsai, T.H.3    Hsu, C.L.4    Yu, C.J.5    Hsueh, P.R.6
  • 13
    • 67749086328 scopus 로고    scopus 로고
    • Substitution of Moxifloxacin for Isoniazid During Intensive Phase Treatment of Pulmonary Tuberculosis
    • PMID: 19406981
    • Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L et al. (2009) Substitution of Moxifloxacin for Isoniazid During Intensive Phase Treatment of Pulmonary Tuberculosis. Am J Respir Crit Care Med 180: 273-80. doi: 10.1164/rccm.200901-0078OC PMID: 19406981
    • (2009) Am J Respir Crit Care Med , vol.180 , pp. 273-280
    • Dorman, S.E.1    Johnson, J.L.2    Goldberg, S.3    Muzanye, G.4    Padayatchi, N.5    Bozeman, L.6
  • 14
    • 63349091494 scopus 로고    scopus 로고
    • Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: A double-blind, randomised, controlled phase II trial
    • PMID: 19345831
    • Conde MB, Efron A, Loredo C, De Souza GR, Graca NP, Cezar MC et al. (2009) Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 373: 1183-1189. doi: 10.1016/S0140-6736(09)60333-0 PMID: 19345831
    • (2009) Lancet , vol.373 , pp. 1183-1189
    • Conde, M.B.1    Efron, A.2    Loredo, C.3    De Souza, G.R.4    Graca, N.P.5    Cezar, M.C.6
  • 15
    • 38949197081 scopus 로고    scopus 로고
    • A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
    • PMID: 18230244
    • Rustomjee R, Lienhardt C, Kanyok T, Davies GR, Levin J, Mthiyane T et al. (2008) A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 12: 128-138. PMID: 18230244
    • (2008) Int J Tuberc Lung Dis , vol.12 , pp. 128-138
    • Rustomjee, R.1    Lienhardt, C.2    Kanyok, T.3    Davies, G.R.4    Levin, J.5    Mthiyane, T.6
  • 16
    • 33746599368 scopus 로고    scopus 로고
    • Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
    • PMID: 16675781
    • Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW et al. (2006) Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 174: 331-338. PMID: 16675781
    • (2006) Am J Respir Crit Care Med , vol.174 , pp. 331-338
    • Burman, W.J.1    Goldberg, S.2    Johnson, J.L.3    Muzanye, G.4    Engle, M.5    Mosher, A.W.6
  • 17
    • 0027331616 scopus 로고
    • Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection
    • PMID: 7902049
    • Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF (1993) Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 148: 1292-1297. PMID: 7902049
    • (1993) Am Rev Respir Dis , vol.148 , pp. 1292-1297
    • Jones, B.E.1    Young, S.M.M.2    Antoniskis, D.3    Davidson, P.T.4    Kramer, F.5    Barnes, P.F.6
  • 18
    • 33144471064 scopus 로고    scopus 로고
    • Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala
    • PMID: 16466035
    • Okwera A, Johnson JL, Luzze H, Nsubuga P, Kayanja H, Cohn DL et al. (2006) Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala. Int J Tuberc Lung Dis 10: 39-44. PMID: 16466035
    • (2006) Int J Tuberc Lung Dis , vol.10 , pp. 39-44
    • Okwera, A.1    Johnson, J.L.2    Luzze, H.3    Nsubuga, P.4    Kayanja, H.5    Cohn, D.L.6
  • 19
    • 41849150709 scopus 로고    scopus 로고
    • Pharmacometrics: A multidisciplinary field to facilitate critical thinking in drug development and translational research settings
    • PMID: 18440922
    • Barrett JS, Fossler MJ, Cadieu KD, Gastonguay MR (2008) Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings. J Clin Pharmacol 48: 632-649. doi: 10.1177/0091270008315318 PMID: 18440922
    • (2008) J Clin Pharmacol , vol.48 , pp. 632-649
    • Barrett, J.S.1    Fossler, M.J.2    Cadieu, K.D.3    Gastonguay, M.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.